These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17932965)

  • 1. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.
    Rubin DT; Cruz-Correa MR; Gasche C; Jass JR; Lichtenstein GR; Montgomery EA; Riddell RH; Rutter MD; Ullman TA; Velayos FS; Itzkowitz S;
    Inflamm Bowel Dis; 2008 Feb; 14(2):265-74. PubMed ID: 17932965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
    Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
    Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.
    Bernstein CN; Eaden J; Steinhart AH; Munkholm P; Gordon PH
    Inflamm Bowel Dis; 2002 Sep; 8(5):356-61. PubMed ID: 12479651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
    Giannini EG; Kane SV; Testa R; Savarino V
    Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases].
    Ioffe AIu
    Lik Sprava; 2005 Jun; (4):45-8. PubMed ID: 16158715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 5-aminosalicylate in preventing colorectal cancer.
    Riyaz S; Hamlin J; Everett S
    Am J Gastroenterol; 2011 Sep; 106(9):1720-1; author reply 1721-2. PubMed ID: 21897414
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
    Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
    Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Subramanian V; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease.
    Munkholm P
    Aliment Pharmacol Ther; 2003 Sep; 18 Suppl 2():1-5. PubMed ID: 12950413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?].
    Desreumaux P; Romano O
    Gastroenterol Clin Biol; 2004 May; 28(5):509. PubMed ID: 15243337
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemoprevention of colorectal cancer in inflammatory bowel disease].
    Han SH; Lee J
    Korean J Gastroenterol; 2014 Jan; 63(1):3-10. PubMed ID: 24463282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
    Ryan BM; Russel MG; Langholz E; Stockbrugger RW
    Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
    Levine JS; Burakoff R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1293-8. PubMed ID: 17567870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
    Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will a 5-ASA a day keep the cancer (and dysplasia) away?
    Rubin DT; Lashner BA
    Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia surveillance - a practical guide.
    Kariyawasam V
    J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():31-2. PubMed ID: 27273037
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid).
    Klotz U
    Arzneimittelforschung; 2012 Feb; 62(2):53-8. PubMed ID: 22344548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.